Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India’s biggest outbound deals.The acquisition would help Sun Pharma further expand its women’s health portfolio with access to






